Greg Friberg
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Greg Friberg
Biomarin Pharmaceutical Inc reported in an 8-K filed August 22, 2024 that Greg Friberg was appointed Executive Vice President, Chief Worldwide Research and Development Officer, effective September 30, 2024. Greg Friberg has spoken on 3 earnings calls across 1 company, most recently for Biomarin Pharmaceutical Inc on February 23, 2026.
“He will continue in his current role until Dr. Greg Friberg assumes the position of Executive Vice President, Chief Worldwide Research and Development Officer, which is expected on September 30, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-09-30–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biomarin Pharmaceutical Inc
Other people whose current roles at this company are on record from its filings.
- Alexander Hardy CEO, Board Member
- Richard A. Meier Chairman
- Brian Mueller CFO
- Daniel Spiegelman CFO
- Dr. C. Greg Guyer CTO
- G. Eric Davis General Counsel
- Andrea Acosta Chief Accounting Officer
- Rashmi Ramchandani Chief Accounting Officer
- Athena Countouriotis Board Member
- Barbara Bodem Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.